Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Use of epoetin in chronic renal failure.

Coyne DW.

JAMA. 2007 Apr 18;297(15):1713-6. No abstract available.

PMID:
17440149
2.

Effects of Epoetin alfa on hemostasis in chronic renal failure.

Tang WW, Stead RA, Goodkin DA.

Am J Nephrol. 1998;18(4):263-73. Review.

PMID:
9653828
3.

Management of the chronic renal failure patient receiving epoetin alfa for the treatment of anemia.

Binkley LS.

Transplant Proc. 1991 Apr;23(2):1831-2. Review. No abstract available.

PMID:
2053169
4.

Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient.

Cohen JA, Brattich M.

ANNA J. 1997 Oct;24(5):574-80; quiz 581. Review.

PMID:
9392740
5.
6.

Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.

Bieber E.

J Reprod Med. 2001 May;46(5 Suppl):521-30. Review.

PMID:
11396386
7.

[Erythropoiesis stimulating agents in clinical practice].

Niemczyk L, Dębowska M.

Wiad Lek. 2014;67(3):413-5. Review. Polish.

PMID:
25782201
8.

Darbepoetin for the anaemia of chronic kidney disease.

Palmer SC, Saglimbene V, Craig JC, Navaneethan SD, Strippoli GF.

Cochrane Database Syst Rev. 2014 Mar 31;(3):CD009297. doi: 10.1002/14651858.CD009297.pub2. Review.

PMID:
24683046
9.

[Current issues in erythropoietin therapy of renal anemia].

Zakar G.

Lege Artis Med. 2007 Oct;17(10):667-73. Review. Hungarian.

PMID:
19227596
10.

Cancer-related anaemia requires higher doses of epoetin alfa than chronic renal failure replacement therapy.

Itri LM.

Nephrol Dial Transplant. 2001 Dec;16(12):2289-93. Review. No abstract available.

PMID:
11733616
11.

[Pharmacological and clinical profiles of long-lasting erythropoiesis-stimulating agent (darbepoetin alfa; NESP].

Nagano N.

Nihon Yakurigaku Zasshi. 2008 Apr;131(4):291-9. Review. Japanese. No abstract available.

PMID:
18408341
12.

Epoetin alfa. Clinical evolution of a pleiotropic cytokine.

Henry DH, Bowers P, Romano MT, Provenzano R.

Arch Intern Med. 2004 Feb 9;164(3):262-76. Review.

PMID:
14769622
13.

Recombinant erythropoietin in clinical practice.

Ng T, Marx G, Littlewood T, Macdougall I.

Postgrad Med J. 2003 Jul;79(933):367-76. Review.

14.

Darbepoetin alfa, a new therapy for the management of anemia of chronic kidney disease.

Hudson JQ, Sameri RM.

Pharmacotherapy. 2002 Sep;22(9 Pt 2):141S-149S. Review.

PMID:
12222584
15.

Current and future challenges in anaemia management.

Levin A, Locatelli F, Muirhead N, Ritz E.

Nephrol Dial Transplant. 2005 Jun;20 Suppl 6:vi1-2. Review. No abstract available.

PMID:
15958819
18.

Myocardial disease, anemia, and erythrocyte-stimulating proteins in chronic kidney disease.

Foley RN.

Rev Cardiovasc Med. 2005;6 Suppl 3:S27-34. Review.

PMID:
16340936
19.

Epoetins and [symbol: see text] darbepoetin alfa in malignant disease.

[No authors listed]

Drug Ther Bull. 2004 Mar;42(3):21-3. Review.

PMID:
15038080
20.

Supplemental Content

Support Center